Sonrotoclax, Zanubrutinib and CD20mab in Untreated MCL Patients
Sonrotoclax, Zanubrutinib and CD20mab in Untreated MCL Patients
Recruiting · NCT06463691 · Registry updated 2025-05-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Sonrotoclax, Zanubrutinib and CD20mab in Untreated MCL Patients | mantle cell lymphoma | Recruiting | Phase 2 | 2025-05-11 | NCT06463691 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Tianjin Medical University Cancer Institute and Hospital | 287 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Tianjin Medical University Cancer Institute and Hospital | Tianjin | China | 36 |